Loading clinical trials...
Loading clinical trials...
The purpose of this study is to evaluate and document longitudinal efficacy in young children implanted bilaterally with MED-EL COMBI 40+ / PULSARCI100/SONATATI100 cochlear implant systems.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Med-El Corporation
NCT07288580 · Treatment of Congenital Hearing Loss Secondary to Biallelic Mutations of the Otoferlin Gene (OTOF)
NCT06782308 · Tinnitus, Subjective, Tinnitus, Bilateral, and more
NCT04915183 · Hearing Loss, Head and Neck Cancer
NCT05572073 · Sensorineural Hearing Loss, Bilateral
NCT05668338 · Hearing Loss
Nemours Children's Clinic
Jacksonville, Florida
Children's Healthcare of Atlanta
Atlanta, Georgia
Cleveland Clinic Foundation
Cleveland, Ohio
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions